X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (70) 70
index medicus (66) 66
hematology (52) 52
male (39) 39
female (38) 38
aged (37) 37
middle aged (37) 37
oncology (32) 32
cancer (31) 31
life sciences (31) 31
rituximab (29) 29
leukemia, lymphocytic, chronic, b-cell - drug therapy (23) 23
adult (22) 22
aged, 80 and over (21) 21
chronic lymphocytic leukemia (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
treatment outcome (19) 19
chronic lymphocytic-leukemia (17) 17
care and treatment (16) 16
chemotherapy (16) 16
cll (16) 16
leukemia (16) 16
abridged index medicus (14) 14
lymphomas (14) 14
retrospective studies (14) 14
cyclophosphamide (13) 13
lymphoma (13) 13
therapy (13) 13
immunology (12) 12
prognosis (12) 12
survival (12) 12
antineoplastic agents - therapeutic use (11) 11
disease-free survival (11) 11
leukemia, lymphocytic, chronic, b-cell - genetics (11) 11
leukemia, lymphocytic, chronic, b-cell - mortality (11) 11
antibodies, monoclonal, murine-derived - administration & dosage (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
chronic lymphatic leukemia (10) 10
follicular lymphoma (10) 10
hemic and lymphatic diseases (10) 10
mutation (10) 10
open-label (10) 10
research (10) 10
fludarabine (9) 9
hematology, oncology and palliative medicine (9) 9
human health and pathology (9) 9
immune system diseases (9) 9
immunotherapy (9) 9
leukemia, lymphocytic, chronic, b-cell - pathology (9) 9
patients (9) 9
activation (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
cyclophosphamide - administration & dosage (8) 8
expression (8) 8
protein kinase inhibitors - therapeutic use (8) 8
elderly (7) 7
human necessities (7) 7
hygiene (7) 7
medical or veterinary science (7) 7
salvage therapy (7) 7
transplantation (7) 7
[sdv.can]life sciences [q-bio]/cancer (6) 6
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (6) 6
[sdv]life sciences [q-bio] (6) 6
animals (6) 6
antimitotic agents (6) 6
antineoplastic agents (6) 6
b-cell lymphoma (6) 6
ibrutinib (6) 6
kaplan-meier estimate (6) 6
leukemia, lymphocytic, chronic, b-cell - complications (6) 6
lymphatic leukemia (6) 6
non-hodgkins-lymphoma (6) 6
phosphorylation (6) 6
preparations for medical, dental, or toilet purposes (6) 6
recurrence (6) 6
time factors (6) 6
vidarabine - analogs & derivatives (6) 6
aged patients (5) 5
analysis (5) 5
antibodies, monoclonal - therapeutic use (5) 5
antibodies, monoclonal, murine-derived - adverse effects (5) 5
antineoplastic agents - pharmacology (5) 5
apoptosis (5) 5
b-cells (5) 5
bendamustine (5) 5
chemistry (5) 5
chronic lymphocytic leukaemia (5) 5
dexamethasone - administration & dosage (5) 5
diagnosis (5) 5
drug therapy (5) 5
elderly-patients (5) 5
france - epidemiology (5) 5
health aspects (5) 5
in-vivo (5) 5
investigating or analysing materials by determining theirchemical or physical properties (5) 5
lymphocytes (5) 5
lymphocytes b (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
lymphoma, large b-cell, diffuse - mortality (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 3, p. e9807
Background Cell survival mediated by integrin engagement has been implicated in cell adhesion-mediated drug resistance. We have recently demonstrated that the... 
Phosphorylation | Starvation | Cell survival | Laboratories | Glycogen | Leukemia | Chemoresistance | Glycogen synthase kinase 3 | Activation | Insulin-like growth factors | Dephosphorylation | Tumor necrosis factor-α | Drug resistance | Kinases | Survival | Cytosol | Fibronectin | Cell adhesion & migration | Scaffolding | Cell lines | Cell adhesion | Apoptosis
Journal Article
European Journal of Haematology, ISSN 0902-4441, 10/2019, Volume 103, Issue 4, pp. 444 - 448
Histiocytic sarcoma is a very rare disease composed of tumour cells derived from monocyte/macrophage lineages, with a median overall survival of six months,... 
Literature reviews | Sarcoma
Journal Article
Leukemia Research, ISSN 0145-2126, 10/2019, Volume 85, p. 106199
Journal Article
Blood, ISSN 0006-4971, 10/2015, Volume 126, Issue 18, pp. 2110 - 2117
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 25, pp. 4211 - 4216
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2017, Volume 176, Issue 1, pp. 37 - 49
Central nervous system involvement ( CNS i) is a rare and poorly reported complication of chronic lymphocytic leukaemia ( CLL ). Establishing cause and effect... 
treatment | magnetic resonance imaging | chronic lymphocytic leukaemia | cerebrospinal fluid | central nervous system | IBRUTINIB | FOLLOW-UP | NEUROLOGIC COMPLICATIONS | BING-NEEL SYNDROME | CEREBROSPINAL-FLUID | CNS INVOLVEMENT | INFILTRATION | LEPTOMENINGEAL INVOLVEMENT | NON-HODGKINS-LYMPHOMA | FLOW-CYTOMETRY | HEMATOLOGY | Pyrazoles - therapeutic use | Prognosis | Humans | Middle Aged | Central Nervous System - pathology | Male | Leukemia, Lymphocytic, Chronic, B-Cell - complications | Aged, 80 and over | Adult | Female | Retrospective Studies | Neoplasm Invasiveness | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Remission Induction | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Survival Analysis | Aged | Disease Management | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemic Infiltration - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Cohort Studies | Chemotherapy | Central nervous system | Cancer | Flow cytometry | Therapy | Chronic lymphatic leukemia | Leukemia | Nervous system | Cerebrospinal fluid | Patients | Survival | Cytometry | Fludarabine | Clonal deletion | Biopsy | Medical prognosis | Deletion | Infiltration | Life Sciences | Hematology | Human health and pathology
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2019, Volume 185, Issue 4, pp. 784 - 788
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2015, Volume 90, Issue 6, pp. 511 - 514
Journal Article
Haematologica, ISSN 0390-6078, 02/2019, p. haematol.2018.207183
While efficient to treat B-cell malignancies, Bruton's tyrosine kinase inhibitors are consistently reported to increase the bleeding risk. Analyzing platelet... 
Journal Article
OncoImmunology, ISSN 2162-4011, 04/2019, Volume 8, Issue 4, p. e1570774
CD8 + T cells are frontline defenders against cancer and primary targets of current immunotherapies. In CLL, specific functional alterations have been... 
phenotypic signature | chronic lymphocytic leukemia | CD8 | supervised learning | multidimensional phenotyping | + | T cells | ACTIVATION | CLL PATIENTS | RECEPTOR | MULTIPLEX IMMUNOHISTOCHEMISTRY | IMMUNOLOGY | B-CELLS | MICROENVIRONMENT | ONCOLOGY | EXPANSION | CD8(+) T cells | CYTOMETRY | EXPRESSION | CANCER-IMMUNITY
Journal Article
Journal Article